Yi-Fang Zeng

Title: Yi-Fang Zeng: Innovator in Antibody Glycoform Remodeling

Introduction

Yi-Fang Zeng is a prominent inventor based in Taipei, Taiwan. He has made significant contributions to the field of biotechnology, particularly in the area of antibody glycoform remodeling. His innovative work has the potential to enhance the efficacy of therapeutic antibodies.

Latest Patents

Yi-Fang Zeng holds a patent for a fusion protein designed for remodeling antibody glycoforms. The patent, titled "Fusion protein for remodeling antibody glycoform," describes a fusion protein that includes a fucosidase or a truncated fragment or mutant thereof, fused with either the N-terminal or C-terminal end of an endoglycosidase or its truncated fragment or mutant. This invention also encompasses a nucleic acid molecule that expresses the fusion protein and a method for remodeling a glycan of an antibody Fc region.

Career Highlights

Yi-Fang Zeng is currently employed at Cho Pharma Inc., where he continues to advance his research and development efforts. His work at the company focuses on innovative solutions in the biotechnology sector, particularly in enhancing antibody therapies.

Collaborations

Some of his notable coworkers include Kuo-Ching Chu and Lin-Ya Huang, who contribute to the collaborative environment at Cho Pharma Inc. Their combined expertise fosters a dynamic research atmosphere.

Conclusion

Yi-Fang Zeng's contributions to antibody glycoform remodeling exemplify the innovative spirit of modern biotechnology. His patent and ongoing work at Cho Pharma Inc. highlight the importance of research in developing more effective therapeutic solutions.